SYDNEY M. FINEGOLD, M.D., F.A.C.P.; JOHN G. BARTLETT, M.D.; ANTHONY W. CHOW, M.D., F.R.C.P.(C); DENNIS J. FLORA, M.D.; SHERWOOD L. GORBACH, M.D.; EDWARD J. HARDER, M.D.; FRANCIS P. TALLY, M.D.
Anaerobic infections are reviewed with emphasis on management. Most anaerobic pulmonary infections respond to penicillin G, even when Bacteroides fragilis (penicillin-resistant) is present. Clindamycin is suitable in penicillin-sensitive patients. Intraabdominal infections have a complex flora usually involving anaerobes, especially B. fragilis. It is desirable to use antimicrobial therapy to cover potential pathogens of all types. Surgical drainage and debridement are extremely important considerations. Anaerobic bacteria were found in 72% of 200 patients with female genital tract infections and were the exclusive isolates in 30%. Surgical therapy is primary, but antimicrobial and anticoagulant therapy are also important. A variety of soft-tissue infections involve anaerobes. Surgery is the major therapeutic approach. Anaerobic endocarditis is uncommon but may be difficult to manage. Chloramphenicol is ordinarily the drug of choice for brain abscess. New antimicrobial agents, which are under investigation and are promising, include new penicillins, new cephalosporins, new tetracyclines, and metronidazole.
FINEGOLD SM, BARTLETT JG, CHOW AW, et al. Management of Anaerobic Infections. Ann Intern Med. 1975;83:375–389. doi: 10.7326/0003-4819-83-3-375
Download citation file:
Published: Ann Intern Med. 1975;83(3):375-389.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use